Pompholyx or dyshidrosis

References

• Fox T. Dyshidrosis: cheiro-pompholyx. Lancet1, 651(1876).
   Google Scholar
• Storrs FJ. Acute and recurrent vesicular hand dermatitis not pompholyx or dyshidrosis. Arch. Dermatol.143(12), 1578–1580 (2007).
   PubMedGoogle Scholar
• Tamer E, Ilhan MN, Polat M et al. Prevalence of skin diseases among pediatric patients in Turkey. J. Dermatol.35(7), 413–418 (2008).
   PubMed Web of Science ®Google Scholar
• Kutzner H, Wurzel RM, Wolff HH. Are acrosyringia involved in the pathogenesis of “dyshidrosis”? Am. J. Dermatopathol.8(2), 109–116 (1986).
   PubMed Web of Science ®Google Scholar
• Chougule A, Thappa DM. Patterns of lower leg and foot eczema in south India. Indian J. Dermatol. Venereol. Leprol.74(5), 458–461 (2008).
   PubMed Web of Science ®Google Scholar
• Ruzicka T, Larsen FG, Galewicz D et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy. Results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch. Dermatol.140(12), 1453–1459 (2004).
   PubMed Web of Science ®Google Scholar
• Ruzicka T, Lynde CW, Jemec GBE et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized double-blind, placebo-controlled, multicentre trial. Br. J. Dermatol.158(4), 808–817 (2008).
   PubMed Web of Science ®Google Scholar
• Marks R. The pathology and pathogenesis of the eczematous reaction. In: Eczema. Marks R (Ed.) Martin Dunitz, London, UK 21–36 (1992).
   Google Scholar
• Lee CS, Lim HW. Cutaneous diseases in Asians. Dermatol. Clin.21(4), 669–677 (2003).
   PubMed Web of Science ®Google Scholar
• Chen JJ, Liang YH, Zhou FS et al. The gene for a rare autosomal dominant form of pompholyx maps to chromosome 18q22.1–18q22.3. J. Invest. Dermatol.126(2), 300–304 (2006).
   PubMed Web of Science ®Google Scholar
• Vocks E, Plotz SG, Ring J. The dyshidrotic eczema area and severity index – a score developed for the assessment of dyshidrotic eczema. Dermatology198(3), 265–269 (1999).
   PubMed Web of Science ®Google Scholar
• Benedek T. Pompholyx of the nail organ and the true onychomycosis. Mycopathol. Mycol. Appl.48(2), 231–259 (1972).
   PubMedGoogle Scholar
• Meneghini CL, Angelini G. Contact and microbial allergy in pompholyx. Contact Derm.5(1), 46–50 (1979).
   PubMed Web of Science ®Google Scholar
• Hindsen M, Bruze M, Christensen OB. Individual variation in nickel patch test reactivity. Am. J. Contact Dermat.10(2), 62–67 (1999).
   PubMedGoogle Scholar
• Gawkrodger DJ, Cook SW, Fell GS et al. Nickel dermatitis: the reaction to oral nickel challenge. Br. J. Dermatol.115(1), 33–38 (1986).
   PubMed Web of Science ®Google Scholar
• Guillet MH, Wierzbicka E, Guillet S et al. A 3-year causative study of pompholyx in 120 patients. Arch. Dermatol.143(12), 1504–1508 (2007).
   PubMedGoogle Scholar
• Bryld LE, Agner T, Menné T. Relation between vesicular eruptions on the hands and tinea pedis, atopic dermatitis and nickel allergy. Acta Derm. Venereol.83(3), 186–188 (2003).
   PubMed Web of Science ®Google Scholar
• Magina S, Barros MA , Ferreira JA , Mesquita-Guimaraes J. Atopy, nickel sensitivity, occupation, and clinical patterns in different types of hand dermatitis. Am. J. Contact Dermat.14(2), 63–68 (2003).
   PubMedGoogle Scholar
• Prystupa K, Rudzki E. Oral tolerance of nickel in patients with dyshidrosis. Contact Derm.42(5), 276–277 (2000).
   PubMedGoogle Scholar
• Yokozeki H, Katayama I, Nishioka K, Kinoshita M, Nishiyama S. The role of metal allergy and local hyperhidrosis in the pathogenesis of pompholyx. J. Dermatol.19(12), 964–967 (1992).
   PubMedGoogle Scholar
• Lodi A, Betti R, Chiarelli G, Urbani CE, Crosti C. Epidemiological, clinical and allergological observations on pompholyx. Contact Derm.26(1), 17–21 (1992).
   PubMed Web of Science ®Google Scholar
• Pigatto PD, Gibelli E, Fumagalli M, Bigardi A, Morelli M, Altomare GF. Disodium cromoglycate versus diet in the treatment and prevention of nickel-positive pompholyx. Contact Derm.22(1), 27–31 (1990).
   PubMed Web of Science ®Google Scholar
• Veien NK, Kaaber K. Nickel, cobalt, and chromium sensitivity in patients with pompholyx (dyshidrotic eczema). Contact Derm.5(6), 371–375 (1979).
   PubMed Web of Science ®Google Scholar
• Stuckert J, Nedorost S. Low-cobalt diet for dyshidrotic eczema patients. Contact Derm.59(6), 361–365 (2008).
   PubMed Web of Science ®Google Scholar
• Pitché P, Boukari M, Tchangai-Walla K. [Factors associated with palmoplantar or plantar pompholyx: a case–control study.] Ann. Dermatol. Venereol.133(2), 139–143 (2006).
   PubMed Web of Science ®Google Scholar
• Nowicki R. [Allergic phenomena in the course of dermatomycoses.] Pol. Merkur. Lekraski14(84), 532–534 (2003).
   PubMedGoogle Scholar
• MacConnachie AA, Smith CC. Pompholyx as a manifestation of HIV infection, response to antiretroviral therapy. Acta Derm. Venereol.87(4), 378–379 (2007).
   PubMed Web of Science ®Google Scholar
• Niinai H, Kawamoto M, Yuge O. Severe pompholyx following endoscopic thoracic sympathectomy for palmar hyperhidrosis. Interact. Cardiovasc. Thorac. Surg.3(4), 593–595 (2004).
   PubMedGoogle Scholar
• Douwes KE, Karrer S, Abels C et al. Does smoking influence the efficacy of bath-PUVA therapy in chronic palmoplantar hand eczema? Photodermatol. Photoimmunol. Photomed.16(1), 25–29 (2000).
   PubMed Web of Science ®Google Scholar
• Man I, Ibbotson SH, Fergusan J. Photoinduced pompholyx: a report of 5 cases. J. Am. Acad. Dermatol.50(1), 55–60 (2004).
   PubMed Web of Science ®Google Scholar
• Pearce VJ, Mortimer PS. Hand dermatitis and lymphoedema. Br. J. Dermatol161(1), 177–180 (2009).
   PubMed Web of Science ®Google Scholar
• Duhra P, Ryatt KS. Haemorrhagic pompholyx in bullous pemphigoid. Clin. Exp. Dermatol.13(5), 342–343 (1988).
   PubMed Web of Science ®Google Scholar
• Barth JH, Venning VA, Wojnarowska F. Palmoplantar involvement in auto-immune blistering disorders – pemphigoid, linear IgA disease and herpes gestationis. Clin. Exp. Dermatol.13(2), 85–86 (1988).
   PubMed Web of Science ®Google Scholar
• Rieger H, Thiem P. Herpes simplex virus infection of the hand. Dtsch. Med. Wochenschr.121(36), 1090–1092 (1996).
   PubMed Web of Science ®Google Scholar
• Parker RK , Guin JD. Hand eczema herpeticum. Cutis52(4), 227–228 (1993).
   PubMed Web of Science ®Google Scholar
• Pitche PT. [Pellagra]. Sante15(3), 205–208 (2005).
   PubMedGoogle Scholar
• Yang CH, Lin WC, Chuang CK et al. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy. Br. J. Dermatol.158(3), 592–596 (2008).
   PubMed Web of Science ®Google Scholar
• Wollina U, Abdel Naser MB. Pharmacotherapy of pompholyx. Expert Opin. Pharmacother.5(7), 1517–1522 (2004).
   PubMed Web of Science ®Google Scholar
• Veien NK, Ølholm Larsen P, Thestrup-Pedersen K et al. Long-term, intermittent treatment of chronic hand eczema with mometasone fuorate. Br. J. Dermatol.140(5), 882–886 (1999).
   PubMed Web of Science ®Google Scholar
• Harper J. Topical corticosteroids for skin disorders in infants and children. Drugs36(Suppl. 5), 34–37 (1988).
   PubMed Web of Science ®Google Scholar
• Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm. Venereol.72(1), 69–71 (1992).
   PubMed Web of Science ®Google Scholar
• Schnopp C, Remling R, Möhrenschläger M et al. Topical tacrolimus (FK 506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J. Am. Acad. Dermatol.46(1), 73–77 (2002).
   PubMed Web of Science ®Google Scholar
• Schurmeyer-Horst F, Luger T, Böhm M. Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema. Dermatology214(1), 99–100 (2007).
   PubMed Web of Science ®Google Scholar
• Belsito DV, Fowler JF Jr, Marks JG Jr et al. Multicenter investigator group: pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis73(1), 31–38 (2004).
   PubMed Web of Science ®Google Scholar
• Hanifin JM, Stevens V, Sheth P et al. Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br. J. Dermatol.105(3), 545–553 (2004).
   Web of Science ®Google Scholar
• Wollina U. Peat: a natural source for dermocosmetics and dermatologic therapy. J. Cutan. Aesthetic Surg.2(1), 17–20 (2009).
   PubMedGoogle Scholar
• Scerri L. Azathioprine in dermatological practice: an overview with special emphasis on its use in non-bullous inflammatory dermatoses. Adv. Exp. Med. Biol.455, 343–348 (1999).
   PubMed Web of Science ®Google Scholar
• Egan CA, Rallis TM, Meadows KP et al. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J. Am. Acad. Dermatol.40(4), 612–614 (1999).
   PubMed Web of Science ®Google Scholar
• Pickenacker A, Luger TA, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch. Dermatol.134(3), 378–379 (1998).
   PubMedGoogle Scholar
• Reitamo S, Granlund H. Cyclosporin A in the treatment of chronic dermatitis of the hands. Br. J. Dermatol.130(1), 75–78 (1994).
   PubMed Web of Science ®Google Scholar
• Semhoun-Ducloux S, Ducloux D, Miguet JP. Mycophenolate mofetil-induced dyshidrotic eczema. Ann. Intern. Med.132(5), 417(2000).
   PubMedGoogle Scholar
• Cheer SM, Foster RH. Alitretinoin. Am. J. Clin. Dermatol.1(5), 307–314 (2000).
   PubMedGoogle Scholar
• Wollina U, Karamfilov T. Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left–right comparison. J. Eur. Acad. Dermatol. Venereol.16(1), 40–42 (2002).
   PubMed Web of Science ®Google Scholar
• Swartling C, Naver H, Lindberg M, Anveden I. Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J. Am. Acad. Dermatol.47(5), 667–671 (2002).
   PubMed Web of Science ®Google Scholar
• Bansal C, Omlin KJ, Hayes CM et al. Novel cutaneous uses for botulinum toxin type A. J. Cosmet. Dermatol.5(3), 268–272 (2006).
   PubMedGoogle Scholar
• Kontochritopoulos G, Gregoriou S, Agiasofitou G et al. Regression of relapsing dyshidtrotic eczema after treatment of concomitant hyperhidrosis with botulinum toxin-A. Dermatol. Surg.33(10), 1289–1290 (2007).
   PubMed Web of Science ®Google Scholar
• Ricci G, Dondi A, Patrizi A, Masi M. Systemic therapy of atopic dermatitis in children. Drugs69(3), 297–306 (2009).
   PubMed Web of Science ®Google Scholar
• Borchard KL, Orchard D. Systemic therapy of paediatric atopic dermatitis: an update. Australas. J. Dermatol.49(3), 123–134 (2008).
   PubMed Web of Science ®Google Scholar
• Hunziker T, Haudenschild-Falb E, Schmidli J et al. [‘Aqua-SUP’ in chronic palmoplantar dermatoses.] Hautarzt38(3), 165–167 (1987).
   PubMed Web of Science ®Google Scholar
• Krutmann J. Phototherapy for atopic dermatitis. Clin. Exp. Dermatol.25(7), 552–528 (2000).
   PubMed Web of Science ®Google Scholar
• Tzaneva S, Kittler H, Thallinger C, Hönigsmann H, Tanew A. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema. Photodermatol. Photoimmunol. Photomed.25(2), 101–105 (2009).
   PubMed Web of Science ®Google Scholar
• Grundmann-Kollmann M, Behrens S, Peter RU et al. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol. Photoimmunol. Photomed.15(2), 87–89 (1999).
   PubMed Web of Science ®Google Scholar
• Grattan CE, Carmichael AJ, Shuttleworth GJ et al. Comparison of topical PUVA with UVA for chronic vesicular hand eczema. Acta Derm. Venereol.71(2), 118–122 (1991).
   PubMed Web of Science ®Google Scholar
• Schmidt T, Abeck D, Boeck K et al. UVA1 irradiation is effective in treatment of chronic vesicular hand eczema. Acta Derm. Venereol.78(4), 318–319 (1998).
   PubMed Web of Science ®Google Scholar
• Polderman MC, Govaert JC, le Cessie S et al. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin. Exp. Dermatol.28(6), 584–587 (2003).
   PubMed Web of Science ®Google Scholar
• Petering H, Breuer C, Herbst R et al. Comparison of localized high-dose UVA1 versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J. Am. Acad. Dermatol.50(1), 68–72 (2004).
   PubMed Web of Science ®Google Scholar
• Jansen GT. Grenz rays: adequate or antiquated? J. Dermatol. Surg. Oncol.4(8), 627–629 (1978).
   PubMedGoogle Scholar
• Stambaugh MD, DeNittis AS, Wallner PE et al. Complete remission of refractory dyshidrotic eczema with the use of radiation therapy. Cutis65(4), 211–214 (2000).
   PubMed Web of Science ®Google Scholar
• Odia S, Vocks E, Rakoski J et al. Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed current. Acta Derm. Venereol.76(6), 472–474 (1996).
   PubMed Web of Science ®Google Scholar
• Wollina U, Uhlemann C, Elstermann D et al. [Therapy of hyperhidrosis with tap water iontophoresis. Positive effect on healing time and lack of recurrence in hand–foot eczema.] Hautarzt49(2), 109–113 (1998).
   PubMed Web of Science ®Google Scholar
• Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am. J. Clin. Dermatol.8(5), 259–270 (2007).
   PubMed Web of Science ®Google Scholar
• Suh L, Coffin S, Leckerman KH, Gelfand JM, Honig PJ, Yan AC. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis. Pediatr. Dermatol.25(5), 528–534 (2008).
   PubMed Web of Science ®Google Scholar
• Chung HJ, Jeon HS, Sung H, Kim MN, Hong SJ. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J. Clin. Microbiol.46(3), 991–995 (2008).
   PubMed Web of Science ®Google Scholar
• Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst. Rev.16(3), CD003871(2008).
   Google Scholar
• Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol. Assess.4(37), 1–191 (2000).
   PubMedGoogle Scholar
• Breuer K, Kapp A, Werfel T. Der Einfluss infektiöser Mikroorganismen auf den Verlauf der atopischen Dermatitis. Allergologie25, 256–263 (2002).
   Web of Science ®Google Scholar
• Sporik R, Kemp AS. Topical triclosan treatment of atopic dermatitis. J. Allergy Clin. Immunol.99(66 Pt1), 861(1997).
   PubMedGoogle Scholar
• Bhargava HN, Leonhard PA. Triclosan: application and safety. Am. J. Infect. Control24(3), 209–218 (1996).
   PubMed Web of Science ®Google Scholar
• Schena D, Papagrigoraki A, Girolomoni G. Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema. Dermatol. Ther.21(Suppl. 2), S35–S38 (2002).
   Google Scholar
• Brockow K, Grabenhorst P, Abeck D et al. Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus-aureus-colonized atopic eczema. Dermatology199(3), 231–236 (1999).
   PubMed Web of Science ®Google Scholar
• Gauger A, Ring J. Antimicrobial Therapy in atopic Eczema . In: Handbook of Atopic Eczema, Volume III. Ring J, Przybilla B, Ruzicka T (Eds). Springer, Berlin – Heidelberg, Germany 492–502 (2006).
   Google Scholar
• Abeck D, Mempel M. Staphylococcus aureus colonisation in atopic dermatitis and its therapeutic implications. Br. J. Dermatol.139(Suppl. 53), 13–16 (1998).
   PubMed Web of Science ®Google Scholar
• Verbist I. The antimicrobial activity of fucidic acid. J. Antimicrob. Chemother.25(Suppl. B), 1–5 (1990).
   PubMed Web of Science ®Google Scholar
• Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin. Exp. Dermatol.25(4), 327–330 (2000).
   PubMed Web of Science ®Google Scholar
• Peeters KABM, Mascini EM, Sanders CJG. Resistance of Staphylococcus aureus to fusidic acid. Int. J. Dermatol.43(3), 235–237 (2004).
   PubMed Web of Science ®Google Scholar
• Ravenscroft JC, Layton AM, Eady EA et al. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br. J. Dermatol.148(5), 1010–1017 (2003).
   PubMed Web of Science ®Google Scholar
• Weinberg E, Fourie B, Allmann B, Toerien A. The use of cefadroxil in superinfected atopic dermatitis. Curr. Ther. Res. Clin. Exp.52, 671–676 (1992).
   Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int. J. Antimicrob. Agents31(1), 12–20 (2008).
   PubMed Web of Science ®Google Scholar
• Hoeger PH. Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis. Pediatr. Allergy Immunol.15(5), 474–477 (2004).
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Sampson H, Harbeck R, Leung DYM. Effects of cefuroxime axetil on S. aureus colonization and superantigen production in atopic dermatitis. J. Allergy Clin. Immunol.108(4), 651–652 (2001).
   PubMed Web of Science ®Google Scholar
• Jones RN, Fritsche TR, Sader HS, Ross JE. Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci. Antimicrob. Agents Chemother.50(7), 2583–2586 (2006).
   PubMed Web of Science ®Google Scholar
• Parish LC, Jorizzo JL, Breton JJ et al. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. Pediatr. Allergy Immunol.18(4), 335–338 (2007).
   PubMed Web of Science ®Google Scholar
• Oranje AP, Chosidow O, Sacchidanand S et al. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study. Dermatology215(4), 331–340 (2007).
   PubMed Web of Science ®Google Scholar
• Koning S, van der Wouden JC, Chosidow O et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br. J. Dermatol.158(5), 1077–1082 (2008).
   PubMed Web of Science ®Google Scholar
• Akdis CA , Akdis M, Bieber T et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy61(8), 969–998 (2006).
   PubMed Web of Science ®Google Scholar